交易 Sage Therapeutics, Inc. - SAGE CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.11 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
SAGE Therapeutics Inc ESG Risk Ratings
High Medium Low Negligible
“C”分數表示在公開報告重大 ESG 數據方面令人滿意的相對 ESG 表現和適度的透明度。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Apr 18, 2024 | 12.97 | 0.83 | 6.84% | 12.14 | 13.43 | 12.03 |
Apr 17, 2024 | 12.47 | -0.40 | -3.11% | 12.87 | 13.26 | 10.85 |
Apr 16, 2024 | 15.51 | 0.46 | 3.06% | 15.05 | 15.69 | 14.93 |
Apr 15, 2024 | 15.20 | -0.16 | -1.04% | 15.36 | 15.52 | 14.98 |
Apr 12, 2024 | 15.39 | -0.70 | -4.35% | 16.09 | 16.20 | 15.23 |
Apr 11, 2024 | 16.51 | 0.08 | 0.49% | 16.43 | 16.65 | 16.15 |
Apr 10, 2024 | 16.37 | 0.25 | 1.55% | 16.12 | 16.48 | 15.75 |
Apr 9, 2024 | 16.47 | 0.04 | 0.24% | 16.43 | 16.98 | 16.18 |
Apr 8, 2024 | 16.55 | 0.35 | 2.16% | 16.20 | 16.70 | 16.13 |
Apr 5, 2024 | 16.31 | -0.03 | -0.18% | 16.34 | 16.71 | 15.80 |
Apr 4, 2024 | 16.52 | -0.39 | -2.31% | 16.91 | 17.44 | 16.41 |
Apr 3, 2024 | 17.10 | 0.00 | 0.00% | 17.10 | 17.32 | 16.67 |
Apr 2, 2024 | 17.18 | -0.42 | -2.39% | 17.60 | 17.60 | 17.13 |
Apr 1, 2024 | 17.86 | -0.61 | -3.30% | 18.47 | 18.53 | 17.69 |
Mar 28, 2024 | 18.66 | -0.23 | -1.22% | 18.89 | 19.08 | 18.41 |
Mar 27, 2024 | 18.96 | 0.32 | 1.72% | 18.64 | 19.13 | 18.56 |
Mar 26, 2024 | 18.49 | -0.56 | -2.94% | 19.05 | 19.05 | 18.32 |
Mar 25, 2024 | 18.61 | -0.32 | -1.69% | 18.93 | 19.43 | 18.52 |
Mar 22, 2024 | 19.17 | -0.72 | -3.62% | 19.89 | 20.08 | 19.06 |
Mar 21, 2024 | 19.81 | 0.10 | 0.51% | 19.71 | 20.09 | 19.14 |
Sage Therapeutics, Inc. Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Thursday, April 25, 2024 | ||
時間 (UTC) 12:00 | 國家 US
| 事件 Q1 2024 SAGE Therapeutics Inc Earnings Call Q1 2024 SAGE Therapeutics Inc Earnings CallForecast(預報) -返回 - |
時間 (UTC) 12:30 | 國家 US
| 事件 Q1 2024 SAGE Therapeutics Inc Earnings Release Q1 2024 SAGE Therapeutics Inc Earnings ReleaseForecast(預報) -返回 - |
Friday, June 14, 2024 | ||
時間 (UTC) 12:30 | 國家 US
| 事件 SAGE Therapeutics Inc Annual Shareholders Meeting SAGE Therapeutics Inc Annual Shareholders MeetingForecast(預報) -返回 - |
Monday, August 5, 2024 | ||
時間 (UTC) 12:30 | 國家 US
| 事件 Q2 2024 SAGE Therapeutics Inc Earnings Release Q2 2024 SAGE Therapeutics Inc Earnings ReleaseForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 7.686 | 6.308 | 1114.2 | 6.868 | 90.273 |
總營業費用 | 554.675 | 467.217 | 517.974 | 714.992 | 483.511 |
銷售/一般/行政費用,總計 | 227.699 | 183.498 | 196.952 | 345.777 | 201.404 |
研究與開發 | 326.163 | 283.166 | 292.714 | 368.815 | 282.107 |
營業收入 | -546.989 | -460.909 | 596.226 | -708.124 | -393.238 |
利息收入(費用),非經營淨值 | 14.19 | 2.883 | 9.597 | 27.804 | 20.334 |
其他,淨值 | 0.015 | 0.134 | 0.25 | 0.082 | 0.022 |
稅前淨收入 | -532.784 | -457.892 | 606.073 | -680.238 | -372.882 |
稅後淨收入 | -532.784 | -457.892 | 606.073 | -680.238 | -372.882 |
未計算非常項目前的淨收益 | -532.784 | -457.892 | 606.073 | -680.238 | -372.882 |
淨收入 | -532.784 | -457.892 | 606.073 | -680.238 | -372.882 |
普通股股東可獲收益 (不含非經常性項目) | -532.784 | -457.892 | 606.073 | -680.238 | -372.882 |
普通股股東可獲收益 (含非經常性項目) | -532.784 | -457.892 | 606.073 | -680.238 | -372.882 |
攤薄淨收入 | -532.784 | -457.892 | 606.073 | -680.238 | -372.882 |
攤薄後加權平均股 | 59.3061 | 58.6702 | 53.0031 | 50.8338 | 46.1212 |
扣除特別項目的每股攤薄盈利 | -8.98363 | -7.8045 | 11.4347 | -13.3816 | -8.08483 |
每股正常攤薄盈利 | -8.98363 | -7.8045 | 11.9581 | -13.3816 | -8.08483 |
非常規項目總計 | |||||
收入 | 7.686 | 6.308 | 1114.2 | 6.868 | 90.273 |
收入成本,共計 | 0.813 | 0.553 | 0.565 | 0.4 | |
毛利 | 6.873 | 5.755 | 1113.64 | 6.468 | |
異常費用(收入) | 0 | 0 | 27.743 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 2.474 | 3.294 | 2.865 | 1.739 | 1.501 |
收入 | 2.474 | 3.294 | 2.865 | 1.739 | 1.501 |
收入成本,共計 | 0.205 | 0.23 | 0.143 | 0.184 | 0.2 |
毛利 | 2.269 | 3.064 | 2.722 | 1.555 | 1.301 |
總營業費用 | 172.931 | 158.764 | 156.767 | 143.219 | 129.908 |
銷售/一般/行政費用,總計 | 75.565 | 65.708 | 67.329 | 61.482 | 52.411 |
研究與開發 | 97.161 | 92.826 | 89.295 | 81.553 | 77.297 |
營業收入 | -170.457 | -155.47 | -153.902 | -141.48 | -128.407 |
利息收入(費用),非經營淨值 | 10.173 | 8.83 | 6.793 | 4.127 | 2.102 |
其他,淨值 | -0.041 | -0.188 | -0.037 | 0.03 | 0.045 |
稅前淨收入 | -160.325 | -146.828 | -147.146 | -137.323 | -126.26 |
稅後淨收入 | -160.325 | -146.828 | -147.146 | -137.323 | -126.26 |
未計算非常項目前的淨收益 | -160.325 | -146.828 | -147.146 | -137.323 | -126.26 |
淨收入 | -160.325 | -146.828 | -147.146 | -137.323 | -126.26 |
普通股股東可獲收益 (不含非經常性項目) | -160.325 | -146.828 | -147.146 | -137.323 | -126.26 |
普通股股東可獲收益 (含非經常性項目) | -160.325 | -146.828 | -147.146 | -137.323 | -126.26 |
攤薄淨收入 | -160.325 | -146.828 | -147.146 | -137.323 | -126.26 |
攤薄後加權平均股 | 59.7696 | 59.6741 | 59.4967 | 59.4281 | 59.2663 |
扣除特別項目的每股攤薄盈利 | -2.68238 | -2.4605 | -2.47318 | -2.31074 | -2.13038 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -2.68238 | -2.4605 | -2.47318 | -2.31074 | -2.13038 |
異常費用(收入) | 0 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 1336.98 | 1800.64 | 2122.37 | 1035.09 | 944.695 |
現金和短期投資 | 1272.49 | 1742.3 | 2099.55 | 1008.39 | 922.776 |
現金等價物 | 162.7 | 294.233 | 1661.08 | 126.705 | 190.943 |
短期投資 | 1109.79 | 1448.06 | 438.467 | 881.688 | 731.833 |
預付的費用 | 50.826 | 39.841 | 22.821 | 26.7 | 21.919 |
總資産 | 1356.45 | 1825.29 | 2159.25 | 1084.15 | 952.705 |
物業/廠房/設備,總計 - 淨額 | 13.43 | 19.125 | 31.819 | 42.897 | 5.643 |
物業/廠房/設備,總計 - 總額 | 19.525 | 24.098 | 38.907 | 47.396 | 7.859 |
累計折舊,總計 | -6.095 | -4.973 | -7.088 | -4.499 | -2.216 |
其他長期資産,總計 | 6.039 | 5.52 | 5.057 | 6.16 | 2.367 |
流動負債總額 | 99.259 | 85.193 | 67.204 | 112.128 | 86.03 |
應付賬款 | 18.95 | 10.45 | 3.691 | 15.266 | 34.036 |
預提費用 | 37.572 | 26.703 | 23.931 | 33.202 | 19.875 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 42.737 | 48.04 | 39.582 | 63.66 | 32.119 |
負債總額 | 103.85 | 96.257 | 86.912 | 139.495 | 89.734 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
其他負債,總計 | 4.591 | 11.064 | 19.708 | 27.367 | 3.704 |
股權 | 1252.6 | 1729.03 | 2072.33 | 944.655 | 862.971 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | |
普通股 | 0.006 | 0.006 | 0.006 | 0.005 | 0.005 |
額外實收資本 | 3291.37 | 3227.47 | 3109.81 | 2587.32 | 1827.02 |
留存收益(累計赤字) | -2028.17 | -1495.39 | -1037.49 | -1643.57 | -963.329 |
Treasury Stock - Common | -0.4 | -0.4 | -0.4 | -0.4 | -0.211 |
其他權益,總計 | -10.206 | -2.66 | 0.415 | 1.295 | -0.515 |
總負債和股東權益 | 1356.45 | 1825.29 | 2159.25 | 1084.15 | 952.705 |
已發行普通股總數 | 59.5091 | 58.937 | 58.3084 | 51.8772 | 46.8883 |
應收賬款總額,淨額 | 13.66 | 18.506 | |||
應收賬款 - 貿易,淨額 | 13.66 | 18.506 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 933.27 | 1064.03 | 1203.44 | 1336.98 | 1465.1 |
現金和短期投資 | 876.052 | 1002.62 | 1129.58 | 1272.49 | 1393.64 |
現金等價物 | 148.712 | 121.416 | 206.557 | 162.7 | 199.826 |
短期投資 | 727.34 | 881.2 | 923.028 | 1109.79 | 1193.81 |
應收賬款總額,淨額 | 22.513 | 15.09 | 15.002 | 13.66 | 18.448 |
應收賬款 - 貿易,淨額 | 22.513 | 15.09 | 15.002 | 13.66 | 18.448 |
預付的費用 | 34.705 | 46.321 | 58.85 | 50.826 | 53.017 |
總資産 | 949.663 | 1082.29 | 1220.69 | 1356.45 | 1486.07 |
物業/廠房/設備,總計 - 淨額 | 8.468 | 10.04 | 11.725 | 13.43 | 14.791 |
物業/廠房/設備,總計 - 總額 | 19.525 | ||||
累計折舊,總計 | -6.095 | ||||
其他長期資産,總計 | 7.925 | 8.221 | 5.524 | 6.039 | 6.178 |
流動負債總額 | 133.004 | 96.807 | 84.692 | 99.259 | 99.687 |
應付賬款 | 11.136 | 9.283 | 12.263 | 18.95 | 7.077 |
預提費用 | 45.985 | 27.789 | 18.369 | 37.572 | 28.299 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 75.883 | 59.735 | 54.06 | 42.737 | 64.311 |
負債總額 | 133.004 | 97.912 | 87.557 | 103.85 | 105.951 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
其他負債,總計 | 0 | 1.105 | 2.865 | 4.591 | 6.264 |
股權 | 816.659 | 984.376 | 1133.13 | 1252.6 | 1380.12 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | |
普通股 | 0.006 | 0.006 | 0.006 | 0.006 | 0.006 |
額外實收資本 | 3357.74 | 3325.74 | 3313.61 | 3291.37 | 3276.42 |
留存收益(累計赤字) | -2536.95 | -2335.32 | -2175 | -2028.17 | -1881.02 |
Treasury Stock - Common | -0.4 | -0.4 | -0.4 | -0.4 | -0.4 |
其他權益,總計 | -3.735 | -5.644 | -5.088 | -10.206 | -14.883 |
總負債和股東權益 | 949.663 | 1082.29 | 1220.69 | 1356.45 | 1486.07 |
已發行普通股總數 | 59.8839 | 59.796 | 59.762 | 59.5091 | 59.4937 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -532.784 | -457.892 | 606.073 | -680.238 | -372.882 |
經營活動産生的現金 | -460.036 | -378.182 | 664.28 | -528.706 | -260.671 |
經營活動産生的現金 | 1.122 | 4.182 | 2.63 | 2.283 | 1.143 |
非現金物品 | 65.955 | 94.034 | 95.306 | 142.591 | 91.856 |
營運資金的變化 | 5.671 | -18.506 | -39.729 | 6.658 | 19.212 |
投資活動産生的現金 | 325.433 | -1002.45 | 442.684 | -143.156 | -512.461 |
資本支出 | -0.937 | -0.372 | -0.345 | -5.751 | -2.86 |
其他投資現金流量項目,總計 | 326.37 | -1002.08 | 443.029 | -137.405 | -509.601 |
融資活動産生的現金 | 3.07 | 13.334 | 426.762 | 607.624 | 659.358 |
融資現金流項目 | -0.043 | -1.385 | -2.503 | -1.244 | |
股票的發行(報廢),淨額 | 3.113 | 14.719 | 426.762 | 610.127 | 660.602 |
現金淨變化 | -131.533 | -1367.3 | 1533.73 | -64.238 | -113.774 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -146.828 | -532.784 | -385.638 | -248.315 | -122.055 |
Cash From Operating Activities | -153.682 | -460.036 | -333.104 | -214.239 | -107.8 |
Cash From Operating Activities | 0.323 | 1.122 | 0.832 | 0.554 | 0.275 |
Non-Cash Items | 16.83 | 65.955 | 52.076 | 37.849 | 20.897 |
Changes in Working Capital | -24.007 | 5.671 | -0.374 | -4.327 | -6.917 |
Cash From Investing Activities | 194.867 | 325.433 | 235.656 | 124.704 | -9.558 |
Other Investing Cash Flow Items, Total | 195.092 | 326.37 | 236.311 | 124.995 | -9.389 |
Cash From Financing Activities | 2.672 | 3.07 | 3.041 | 1.812 | 1.799 |
Issuance (Retirement) of Stock, Net | 3.301 | 3.113 | 3.08 | 1.836 | 1.799 |
Net Change in Cash | 43.857 | -131.533 | -94.407 | -87.723 | -115.559 |
Capital Expenditures | -0.225 | -0.937 | -0.655 | -0.291 | -0.169 |
Financing Cash Flow Items | -0.629 | -0.043 | -0.039 | -0.024 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Bio Therapeutic Drugs |
215 1st St
CAMBRIDGE
MASSACHUSETTS 02142
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 610,000 多名交易者,選擇與 Capital.com 交易